ContraVir Pharmaceuticals Inc.

(CTRV) Trade

By |

Profile

ContraVir Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. The company focuses on developing two novel oral compounds to treat HBV infection. CRV431 is a cyclophilin inhibitor that targets specific isomerases that play an important role in protein folding in health and in disease. TXL is a nucleotide pro-drug of tenofovir that inhibits hepatitis B viral replication and targets the liver, the reservoir for the hepatitis B virus.

Contact Information

Website: www.contravir.com
Email: info@contravir.com
Main Phone: +1 732 902-4000
Address: 399 Thornall Street, First Floor
State: NJ
City / Town: Edison
Country: USA
Postal Code: 08837

Issuer Information

Exchange: NSC
CEO: Robert T. Foster
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

ContraVir Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. The company focuses on developing two novel oral compounds to treat HBV infection. CRV431 is a cyclophilin inhibitor that targets specific isomerases that play an important role in protein folding in health and in disease. TXL is a nucleotide pro-drug of tenofovir that inhibits hepatitis B viral replication and targets the liver, the reservoir for the hepatitis B virus.

Contact Information

Website: www.contravir.com
Email: info@contravir.com
Main Phone: +1 732 902-4000
Address: 399 Thornall Street, First Floor
State: NJ
City / Town: Edison
Country: USA
Postal Code: 08837

Issuer Information

Exchange: NSC
CEO: Robert T. Foster
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.96 $ -0.24 (-4.62%)
Last Price 4.96 Change $ -0.24 Change % -4.62 Tick N/A
Bid 4.75 Bid Size 100.00 Ask 4.92 Ask Size 100.00
Open 4.84 High 5.20 Low 4.55 Prev Close 5.20
Last Trade Volume 858,216 52 Wk Hi 112.70 52 Wk Low 4.10
Market Cap 4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 802,770.00 EPS (TTM) -81.90 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 8
Number of Buys 0 8
Number of Sells 0 0
Net Activity 0 834517
Last 10 Buys Shares
John Cavan 1,000
James Sapirstein 1,000
James Sapirstein 1,000
James Sapirstein 1,000
John P. Brancaccio 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/20/17 04/20/17 04/20/17 04/20/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 2